Comment on: Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood

Mov Disord. 2022 May;37(5):1120-1121. doi: 10.1002/mds.29008.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Ataxin-3 / genetics
  • Humans
  • Machado-Joseph Disease* / genetics
  • Nuclear Proteins
  • Peptides

Substances

  • Nuclear Proteins
  • Peptides
  • polyglutamine
  • Ataxin-3